These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9186844)
1. Effects of long-term administration of octreotide on sodium retention and atrial natriuretic peptide in carbon tetrachloride-induced cirrhotic rats. Wang SS; Lee FY; Wu SL; Hwu CM; Chien CH; Lee SD; Tsai YT; Chao Y; Chen CC; Wang PS J Hepatol; 1997 May; 26(5):1128-34. PubMed ID: 9186844 [TBL] [Abstract][Full Text] [Related]
2. Impaired natriuretic response to atrial natriuretic peptide in the isolated kidney of rats with experimental cirrhosis. Panos MZ; Gove C; Firth JD; Raine AE; Ledingham JG; Westaby D; Williams R Clin Sci (Lond); 1990 Jul; 79(1):67-71. PubMed ID: 2167793 [TBL] [Abstract][Full Text] [Related]
3. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites. López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268 [TBL] [Abstract][Full Text] [Related]
4. Blunted systemic, splanchnic, and renal hemodynamic responses to atrial natriuretic peptide in rats with cirrhosis. Ohsuga M; Moreau R; Hartleb M; Komeichi H; Lebrec D J Hepatol; 1994 Jan; 20(1):91-6. PubMed ID: 8201228 [TBL] [Abstract][Full Text] [Related]
5. Blunted natriuretic response to human urine extracts with Na+,K(+)-ATPase inhibiting activity in experimental cirrhosis. Asbert M; Clària J; Jiménez W; Arroyo V; Ros J; Gaya J; Rivera F; Rodés J J Hepatol; 1994 May; 20(5):660-5. PubMed ID: 8071545 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. Martin PY; Ohara M; Gines P; Xu DL; St John J; Niederberger M; Schrier RW J Clin Invest; 1998 Jan; 101(1):235-42. PubMed ID: 9421486 [TBL] [Abstract][Full Text] [Related]
7. Renal effects of atrial natriuretic peptide in cirrhotic rats with and without captopril pretreatment. Brunkhorst R; Wrenger E; Malcharzik C; Brabant G; Koch KM Nephron; 1993; 64(2):275-81. PubMed ID: 8321362 [TBL] [Abstract][Full Text] [Related]
8. Effects of chronic octreotide treatment on renal changes during cirrhosis in rats. Jonassen TE; Christensen S; Sørensen AM; Marcussen N; Flyvbjerg A; Andreasen F; Petersen JS Hepatology; 1999 May; 29(5):1387-95. PubMed ID: 10216120 [TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide, arginine vasopressin, aldosterone and plasma renin activity in carbon tetrachloride-induced cirrhosis in rats. Elias AN; Vaziri ND; Domurat ES; Pandian MR; Ansari MA; Yazdani M J Pharmacol Exp Ther; 1990 Jan; 252(1):438-41. PubMed ID: 2137178 [TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis. Salerno F; Badalamenti S; Moser P; Lorenzano E; Incerti P; Dioguardi N Gastroenterology; 1990 Apr; 98(4):1063-70. PubMed ID: 2138104 [TBL] [Abstract][Full Text] [Related]
12. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis. Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146 [TBL] [Abstract][Full Text] [Related]
13. Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats. Park KS; Li Y; Zhang Y; Gerbes AL; Liu H; Swain MG; Lee SS Br J Pharmacol; 2003 May; 139(1):81-8. PubMed ID: 12746226 [TBL] [Abstract][Full Text] [Related]
14. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983 [TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic factor: reduced cardiac content in cirrhotic rats with ascites. Jiménez W; Martinez-Pardo A; Arroyo V; Gaya J; Rivera F; Rodés J Am J Physiol; 1986 Apr; 250(4 Pt 2):F749-52. PubMed ID: 2938485 [TBL] [Abstract][Full Text] [Related]
16. Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Koepke JP; Jones S; DiBona GF Am J Physiol; 1987 May; 252(5 Pt 2):R1019-23. PubMed ID: 2953257 [TBL] [Abstract][Full Text] [Related]
17. Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: pathophysiological and clinical implications. Angeli P; Caregaro L; Menon F; Sacerdoti D; De Toni R; Merkel C; Gatta A Hepatology; 1992 Dec; 16(6):1389-94. PubMed ID: 1446894 [TBL] [Abstract][Full Text] [Related]
18. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects. Skorecki KL; Leung WM; Campbell P; Warner LC; Wong PY; Bull S; Logan AG; Blendis LM Am J Med; 1988 Sep; 85(3):375-82. PubMed ID: 2843047 [TBL] [Abstract][Full Text] [Related]
19. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure. Ginès P; Titó L; Arroyo V; Llach J; Salmerón JM; Ginès A; Jiménez W; Badalamenti S; Rivera F; Rodés J Gastroenterology; 1992 Jan; 102(1):280-6. PubMed ID: 1290472 [TBL] [Abstract][Full Text] [Related]
20. Haemodynamic responses to a ring-deleted analogue of atrial natriuretic peptide in rats with cirrhosis. Moreau R; Tazi KA; Komeichi H; Pussard E; Lebrec D Liver; 2000 Feb; 20(1):88-92. PubMed ID: 10726965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]